Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
5 recalls in 8 months for troubled heart devices | Interventional echocardiographers play a key role | AI spots heart defects
Friday, August 18, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces yet another recall, the fifth of 2023, for troubled heart devices

The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

FDA announces yet another recall, the fifth of 2023, for troubled heart devices

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. 
READ MORE >

Interventional echocardiographers play a key role in the treatment of structural heart disease

Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.

READ MORE >
Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst
Share on Twitter Share on Facebook Share on Linkedin

Interventional echocardiographers play a key role in the treatment of structural heart disease

Share on Twitter Share on Facebook Share on Linkedin
Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst
Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.
READ MORE >

AI spots critical heart defects missed by the human eye

“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 

READ MORE >
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
Share on Twitter Share on Facebook Share on Linkedin

AI spots critical heart defects missed by the human eye

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 
READ MORE >

Featured Articles

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. 

READ MORE >
Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system
Share on Twitter Share on Facebook Share on Linkedin

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

Share on Twitter Share on Facebook Share on Linkedin
Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system
The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. 
READ MORE >

2 key reasons the use of AI in echocardiography is growing

Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.

READ MORE >
Video of Partho Sengupta, MD, explaining two major shifts in AI for echocardiography at ASE 2023. These include GPT and deep learning to automate measurements. #ASE23 #ASE2023 #ASE #AI
Share on Twitter Share on Facebook Share on Linkedin

2 key reasons the use of AI in echocardiography is growing

Share on Twitter Share on Facebook Share on Linkedin
Video of Partho Sengupta, MD, explaining two major shifts in AI for echocardiography at ASE 2023. These include GPT and deep learning to automate measurements. #ASE23 #ASE2023 #ASE #AI
Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.
READ MORE >

FDA clears 2 new AI models that help with the diagnosis and treatment of arrhythmias

The two algorithms are now commercially available on a price-per-use basis.

READ MORE >
CathVision ECGenius high fidelity EP recording system showing His bundle pacing demo at HRS 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

FDA clears 2 new AI models that help with the diagnosis and treatment of arrhythmias

Share on Twitter Share on Facebook Share on Linkedin
CathVision ECGenius high fidelity EP recording system showing His bundle pacing demo at HRS 2023. Photo by Dave Fornell
The two algorithms are now commercially available on a price-per-use basis.
READ MORE >

In Case You Missed It

Surgeon sues hospital after being fired for discussing TAVR concerns with media

The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.

READ MORE >
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
Share on Twitter Share on Facebook Share on Linkedin

Surgeon sues hospital after being fired for discussing TAVR concerns with media

Share on Twitter Share on Facebook Share on Linkedin
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.
READ MORE >

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

READ MORE >
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Share on Twitter Share on Facebook Share on Linkedin
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.
READ MORE >

In Other News

Race for AI dominance: 5 points to ponder about US v. China

AI that’s intended to let cars drive themselves can be repurposed to let tanks level cities. And AI can just as easily weaponize a virus as diagnose it. These are not secrets.

READ MORE >
USA China artificial intelligence race
Share on Twitter Share on Facebook Share on Linkedin

Race for AI dominance: 5 points to ponder about US v. China

Share on Twitter Share on Facebook Share on Linkedin
USA China artificial intelligence race
AI that’s intended to let cars drive themselves can be repurposed to let tanks level cities. And AI can just as easily weaponize a virus as diagnose it. These are not secrets.
READ MORE >

Fearing delays, American College of Radiology urges CMS not to leave PET payment decisions up to MACs

ACR is concerned such a scenario would result in delayed and highly variable coverage determinations across the U.S. 

READ MORE >
brain money alzheimer dementia
Share on Twitter Share on Facebook Share on Linkedin

Fearing delays, American College of Radiology urges CMS not to leave PET payment decisions up to MACs

Share on Twitter Share on Facebook Share on Linkedin
brain money alzheimer dementia
ACR is concerned such a scenario would result in delayed and highly variable coverage determinations across the U.S. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Abbott recalls heart monitoring tech | Redo TAVR with balloon-expandable valves | FDA clears new clot-removing device
Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup